Hyperthermia Enhances the Effects of ICI by Increasing PD-L1 Expression Through Induction of CD8 + Cell Infiltration
Anticancer Research · 2026
DOI: 10.21873/anticanres.18385 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Naotsugu Haraguchi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery, Kindai University Nara Hospital, Nara, Japan; nharaguchi@gesurg.med.osaka-u.ac.jp. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, B7-H1 Antigen, Immune Checkpoint Inhibitors, Hyperthermia, Induced.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterological Surgery, Kindai University Nara Hospital, Nara, Japan; nharaguchi@gesurg.med.osaka-u.ac.jp.
- Department of Molecular Pathology, Division of Health Science, Graduate School of Medicine, The University of Osaka, Osaka, Japan.
- Osaka Cancer Immuno-Chemotherapy Center, Osaka, Japan.
Zitieren
APA
Haraguchi, N., Yokoyama, Y., Kubota, Y., Kouda, S., Yamamoto, H., Shibata, S., Takeda, H., Yamamoto, H., & Takeda, T. (2026). Hyperthermia Enhances the Effects of ICI by Increasing PD-L1 Expression Through Induction of CD8 + Cell Infiltration. Anticancer Research. https://doi.org/10.21873/anticanres.18385
Vancouver
Haraguchi N, Yokoyama Y, Kubota Y, Kouda S, Yamamoto H, Shibata S, et al. Hyperthermia Enhances the Effects of ICI by Increasing PD-L1 Expression Through Induction of CD8 + Cell Infiltration. Anticancer Research. 2026. doi:10.21873/anticanres.18385
BibTeX
@article{Haraguchi2026,
author = {Haraguchi, Naotsugu and Yokoyama, Yuhki and Kubota, Yui and Kouda, Shihori and Yamamoto, Hiroyuki and Shibata, Satoshi and Takeda, Hiroko and Yamamoto, Hirofumi and Takeda, Tsutomu},
title = {Hyperthermia Enhances the Effects of ICI by Increasing PD-L1 Expression Through Induction of CD8 + Cell Infiltration},
journal = {Anticancer Research},
year = {2026},
doi = {10.21873/anticanres.18385}
}
EUVIMED